Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide

Biochemical Journal

Volumn 348, Issue 1, 2000, Pages 137-144

  Ward, Robin V ^a,b   Jennings, Kevin H ^a   Jepras, Robert ^a   Neville, William ^a   Owen, Davina E ^a   Hawkins, Julie ^a   Christie, Gary ^a   Davis, John B ^a   George, Ashley ^a,c   Karran, Eric H ^a,b   Howlett, David R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c Cerebrus Limited   (United Kingdom)

Author keywords

Alzheimer's disease; Density gradient centrifugation; Protofibrils

Indexed keywords

AMYLOID BETA PROTEIN; NEUROTOXIN; OLIGOMER;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL VIABILITY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTROPHORESIS; EMBRYO; FRACTIONATION; HIPPOCAMPUS; IMMUNOASSAY; MOLECULAR WEIGHT; NERVE CELL; NERVE DEGENERATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CENTRIFUGATION, DENSITY GRADIENT; CHEMICAL FRACTIONATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIPPOCAMPUS; IMMUNOASSAY; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0034658615     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3480137     Document Type: Article

References (42)

1. 1 Glenner, G. G. and Wong, C. W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135
2. 2 Tanzi, R. E., St George-Hyslop, P. H. and Gusella, J. F. (1989) Molecular genetic approaches to Alzheimer's disease. Trends Neurosci. 12, 152-158
3. 3 Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498
4. 4 Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L. and Neve, R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420
5. 5 Behl, C. and Schubert, D. (1993) Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid beta peptide toxicity. Neurosci. Lett. 154, 1-4
6. 6 Iversen, L. L., Mortishiresmith, R. J., Pollack, S. J. and Shearman, M. S. (1995) The toxicity in-vitro of beta-amyloid protein. Biochem. J. 311, 1-16
7. 7 Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro, the role of peptide assembly state. J. Neurosci. 13, 1676-1687
8. 8 Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P. and Roberts, G. W. (1995) Aggregation state and neurotoxic properties of alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32
9. 9 Miyakawa, T., Katsuragi, S., Watanabe, K., Shimoji, A. and Ikeuchi, Y. (1986) Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol. (Berlin) 70, 202-208
10. 10 Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M. and Selkoe, D. J. (1987) Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 84, 6953-6957
11. 11 Seilheimer, B., Bohrmann, B., Bondolfi, L., Muller, F., Stuber, D. and Dobeli, H. (1997) The toxicity of the Alzheimers beta-amyloid peptide correlates with a distinct fiber morphology. J. Struct. Biol. 119, 59-71
12. 12 Roher, A. E., Chaney, M O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A. et al. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631-20635
13. 13 Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L. et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central-nervous-system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
14. 14 Kuo, Y. M., Emmerling, M. R., Vigo Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081
15. 15 Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B. and Selkoe, D. J. (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell-culture. J. Biol. Chem. 270, 9564-9570
16. 16 Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B. and Selkoe, D. J. (1998) Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell-culture and stabilization of monomer by congo red. Biochemistry 37, 3602-3611
17. 17 Jarrett, J. T., Berger, E. P. and Lansbury, Jr., P. T. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697
18. 18 Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A. and Teplow, D. B. (1996) On the nucleation and growth of amyloid beta-protein fibrils - detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129
19. 19 Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M. and Teplow, D. B. (1997) Amyloid beta-protein fibrillogenesis - detection of a protofibrillar intermediate. J. Biol. Chem 272, 22364-22372
20. 20 Harper, J. D., Lieber, C. M. and Lansbury, P. T. (1997) Atomic-force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimers-disease amyloid-beta protein. Chem. Biol. 4, 951-959
21. 21 Pike, C. J., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1991) Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol 207, 367-368
22. 22 Behl, C., Davis, J. B., Lesley, R. and Schubert, D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827
23. 23 Shearman, M. S., Ragan, C. I. and Iversen, L. L. (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc. Natl. Acad. Sci. U.S.A. 91, 1470-1474
24. 24 Howlett, D. R., Perry, A. E., Godfrey, F., Swatton, J. E., Jennings, K. H., Spitzfaden, C., Wadsworth, H., Wood, S. J. and Markwell, R. E. (1999) Inhibition of beta-amyloid peptide fibrillization by a novel series of benzofurans. Biochem. J. 340, 283-289
25. 25 Ida, N., Hartmann, T., Pantel, J., Schroder, J., Zerfass, R., Forstl, H., Sandbrink, R., Masters, C. L. and Beyreuther, K. (1996) Analysis of heterogeneous βA4 peptides in human cerebrospinal-fluid and blood by a newly developed sensitive western-blot assay. J. Biol. Chem. 271, 22908-22914
26. 26 Provencher, S. W. (1982) CONTIN: A constrained regularization method for inverting data represented by linear algebraic or integral equations. Comput. Phys. Commun. 27, 213-227
27. 27 Laemmli, U. K. and Favre, M. (1973) Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 80, 575-599
28. 28 Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354
29. 29 Pecora, R. (1985) in Dynamic Light Scattering: Applications of Photon Correlation Spectroscopy, Plenum Press, New York
30. 30 Naslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B. and Greengard, P. (1994) Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl. Acad. Sci. U.S.A. 91, 8378-8382
31. 31 Kuo, Y. M., Emmerling, M. R., Woods, A. S., Cotter, R. J. and Roher, A. E. (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem. Biophys. Res. Commun 237, 188-191
32. 32 Pike, C. J., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1991) In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314
33. 33 Glenner, G. G. (1980) Amyloid deposits and amyloidoses. The beta-fibrilloses. N. Engl. J. Med. 302, 1283-1292
34. 34 Howlett, D. R., Ward, R. V., Bresciani, L., Jennings, K. H., Christie, G., Allsop, D., Gray, C. W. and Karren, K. H. (1999) Identification of a high molecular weight toxic species of beta-amyloid. Alzheimer Rep. 2, 171-177
35. 35 Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J. and Teplow, D. B. (1999) Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945-25952
36. 36 Lansbury, P. T. (1999) Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. U.S.A. 96, 3342-3344
37. 37 Hartley, D. M., Walsh, D. M., Ye, C. P. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B. and Selkoe, D. J. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884
38. 38 Howlett, D., Cutler, P., Heales, S. and Camilleri, P. (1997) Hemin and related porphyrins inhibit beta-amyloid aggregation. FEBS Lett. 417, 249-251
39. 39 Howlett, D. R., George, A. R., Owen, D. E., Ward, R. V. and Markwell, R. E. (1999) Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem. J. 343, 419-423
40. 40 George, A. R. and Howlett, D. R. (1999) Computationally derived structural models of beta amyloid found in Alzheimer's disease plaques and its interaction with possible aggregation inhibitors. Biopolymers 50, 733-741
41. 41 Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. and Ihara, Y. (1994) Visualisation of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43) Neuron 13, 45-53
42. 42 Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W. et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870